Smith & Nephew SNATS, Inc.

SNN Healthcare Medical Devices

Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.

31.11 0.90 −2.81%
Market cap
$13.4B
P/E
38.9×
Fwd P/E
18.9×
Dividend yield
2.49%
F-score
7/9
Altman Z
3.49
Beneish M
−2.70
Dividend safety
61/100

Smith & Nephew SNATS, Inc. (SNN) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Smith & Nephew SNATS, Inc. (SNN) trades at a P/E ratio of 38.9×. Over the past ten years it has ranged from 18.2× (September 2022) to 47.2× (September 2025); the current reading is higher than 94% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 40.0× 33.48%
FY2024 30.0× (8.45%)
FY2023 32.7× 2.42%
FY2022 32.0× 3.67%
FY2021 30.8× (11.84%)
FY2020 35.0× 7.59%
FY2019 32.5× 6.52%
FY2018 30.5× (1.57%)
FY2017 31.0× 16.37%
FY2016 26.6× (15.76%)

Quarterly newest first

Period P/E ratio Change
Jun 2023 39.3× 23.02%
Dec 2022 32.0× 37.89%
Jun 2022 23.2× (24.82%)
Dec 2021 30.8× (21.92%)
6 more quarters

Against its own ten years

Low 18.2× High 47.2×
Ten-year median 31.9×
Current reading's percentile 93

P/E ratio against peers

Company P/E ratio
BRKR Bruker Corporation compare n/m
GKOS Glaukos Corporation compare n/m
TXG 10x Genomics compare n/m
BIO Bio-Rad Laboratories, Inc. compare 9.7×
BIO.B Bio-Rad Laboratories, Inc. compare 9.9×
GMED Globus Medical, Inc. compare 19.5×
PODD Insulet Corporation compare 25.2×
SNN Smith & Nephew SNATS, Inc. 38.9×
PEN Penumbra, Inc. compare 80.3×
Medical Devices industry median 25.6×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on SNN